- Roche Diagnostics Corp.
- LifeScan Inc.
- Johnson & Johnson
- Abbott Laboratories Inc.
- Novartis AG
- Bayer Diagnostics
- Bayer AG
- Applied Biosystems Inc.
- Digene Corp.
- Abbott Diagnostics
- Takeda Oncology
- Millennium Predictive Medicine Inc.
- Gen-Probe Inc.
- Chugai Pharmaceutical Co. Ltd.
- Third Wave Technologies Inc.
- Molecular Staging Inc.
- Celera Corp.
- Applied Biosystems Group
- deCODE genetics EHF
- Incyte Corp.
- Partners HealthCare Ctr. for Personalized Gen. Med
- Affymetrix Inc.
- Becton Dickinson & Co.
- Roche buys Boehringer Mannheim and DePuy from Corange
- bioMerieux, Pierre Fabre merge; then part ways
- Chiron, Roche settle diagnostic patent litigation
- Roche acquires AVL Medical Instruments
- Roche to promote Digene's HPV test
- Millennium, Roche develop rheumatoid arthritis diagnostic
- Roche and deCode develop DNA-based tests
- Roche subscribes to Incyte Pharmaceuticals' genomics database
- Roche joins Affymetrix to develop new PCR GeneChip tests
- Affymetrix and Roche Bioscience in GeneChip deal
- deCode licenses Affymetrix's GeneChip technology
- Millennium enters five-year oncology test deal with Becton
- Roche buys PCR from Cetus
- Roche acquires Cetus PCR rights for $300M plus $30M royalties
- Cetus merges into Chiron creating major force in biotech.
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. firstname.lastname@example.org.
All fields are required.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.